-Activation of the death receptor Fas has been reported to produce a two-phase intracellular Ca 2ϩ release response in coronary arterial myocytes (CAMs), which consists of local Ca 2ϩ bursts via lysosomal transient potential receptor-mucolipin 1 (TRP-ML1) channels and consequent Ca 2ϩ release from the sarcoplasmic reticulum (SR). The present study was designed to explore the molecular mechanism by which lysosomal Ca 2ϩ bursts are coupled with SR Ca 2ϩ release in mouse CAMs and to determine the functional relevance of this lysosome-associated two-phase Ca 2ϩ release to apoptosis, a common action of Fas activation with Fas ligand (FasL). By confocal microscopy, we found that transfection of CAMs with TRP-ML1 small interfering (si)RNA substantially inhibited FasL (10 ng/ml)-induced lysosome Ca 2ϩ bursts and consequent SR Ca 2ϩ release. In contrast, transfection of CAMs with plasmids containing a full-length TRP-ML1 gene enhanced FasL-induced two-phase Ca 2ϩ release. We further demonstrated that FasL significantly increased the colocalization of the lysosomal marker Lamp1 with ryanodine receptor 3 and enhanced a dynamic trafficking of lysosomes to the SR. When CAMs were treated with TRP-ML1 siRNA, FasL-induced interactions between the lysosomes and SR were substantially blocked. Functionally, FasL-induced apoptosis and activation of calpain and calcineurin, the Ca 2ϩ sensitive proteins that mediate apoptosis, were significantly attenuated by silencing TRP-ML1 gene but enhanced by overexpression of TRP-ML1 gene. These results suggest that TRP-ML1 channel-mediated lysosomal Ca 2ϩ bursts upon FasL stimulation promote lysosome trafficking and interactions with the SR, leading to apoptosis of CAMs via a Ca 2ϩ -dependent mechanism.
signaling lysosomes; transient receptor potential channel; Ca 2ϩ mobilization; programmed cell death LYSOSOME-MEDIATED SIGNALING is a novel mechanism that regulates intracellular Ca 2ϩ levels in a variety of mammalian cells (15, 18) . It has been reported that lysosomes contain high levels of Ca 2ϩ , which serve as an important intracellular Ca 2ϩ store as does the sarcoplasmic reticulum (SR; Ref. 9) . In response to different physiological and pathological stimulations, lysosomal Ca 2ϩ can be mobilized or released to mediate molecular trafficking or recycling and to control vesicular fusion events associated with lysosomes (15, 19, 22) . Recently, this lysosomal Ca 2ϩ release is found to be mediated by transient receptor potential-mucolipin 1 (TRP-ML1) channel, a
Mcoln1 gene product (26, 27, 31, 37, 39) . In this regard, we have reported that TRP-ML1 channels in lysosomes of arterial smooth muscle cells are permeable to Ca 2ϩ and importantly participate in the Ca 2ϩ responses to agonists such as endothelin-1 (ET-1) and Fas ligand (FasL; Refs. [37] [38] [39] , which are characterized by a two-phase intracellular Ca 2ϩ release. It has been indicated that the Ca 2ϩ releases via lysosomal TRP-ML1 channels and from the SR constitute the first and second phase of the Ca 2ϩ response to these agonists, respectively. Although Ca 2ϩ -induced Ca 2ϩ release (CICR) has been demonstrated to couple TRP-ML1 channel-mediated lysosomal Ca 2ϩ bursts (the 1st phase) to the Ca 2ϩ release from the SR (the 2nd phase; Refs. 4, 38) , this CICR is temporally very different from the classical CICR because it has a long time delay from the first to second phase of the Ca 2ϩ release. It remains unknown how this long time delay between two phases of the Ca 2ϩ release occurs. Given that lysosomes can be clustered and traffic toward different organelles within cells (12) , it is possible that lysosomal trafficking activated by its Ca 2ϩ bursts moves them to aggregate around the SR. This may form a trigger zone to activate the Ca 2ϩ release from the SR as proposed by Kinnear et al. (12) . The present study tested this hypothesis by using mouse coronary arterial myocytes (CAMs), and FasL as a potent stimulator of the two-phase Ca 2ϩ release in CAMs was used to determine whether TRP-ML1-mediated Ca 2ϩ release stimulates lysosome trafficking to the SR, where a large release of Ca 2ϩ is triggered. The present study also determined the physiological or pathological relevance of this TRP-ML1 channel-mediated two-phase Ca 2ϩ release. It is well known that FasL is a type II transmembrane protein that belongs to the tumor necrosis factor (TNF) superfamily, which can induce apoptosis by binding to its receptor, Fas (8) . However, it remains unknown whether FasL-induced apoptosis of CAMs is associated with its action on the two-phase intracellular Ca 2ϩ release mediated by TRP-ML1 channels. Previous studies have indicated that severe Ca 2ϩ dysregulation may promote cell necrosis while controlled intracellular Ca 2ϩ increases induced by mild insults can promote apoptosis (17, 25) . We therefore hypothesized that FasL-induced lysosomal Ca 2ϩ bursts and consequent global Ca 2ϩ increase may promote apoptosis in CAMs, in which activation of TRP-ML1 channels may play a critical role due to its triggering action in the two-phase Ca 2ϩ response to FasL stimulation. To test this hypothesis, we used flow cytometry to address the role of TRP-ML channels in FasL-induced apoptosis in CAMs. By biochemical analysis, we also determined the activity of relevant proteases to apoptosis in CAMs with and without inhibition of TRP-ML1 channel activity or its gene silencing and overexpression. Our findings support the view that FasL induces apoptosis in CAMs through activation of lysosomal TRP-ML1 channels and consequent two-phase intracellular Ca 2ϩ release in these cells.
MATERIALS AND METHODS
Isolation and culture of mouse CAMs. Mice were purchased from Jackson Laboratory. Eight-week-old male and female mice were used in these experiments. All experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Virginia Commonwealth University. Mouse CAMs were isolated from mice as previously described (30) . In brief, mice were deeply anesthetized with an intraperitoneal injection of pentobarbital sodium (25 mg/kg). Their heart was excised with an intact aortic arch and immersed in a petri dish filled with ice-cold Krebs-Henseleit (KH) solution (20 mM HEPES, 128 mM NaCl, 2.5 mM KCl, 2.7 mM CaCl 2, 1 mM MgCl2, and 16 mM glucose at pH 7.4). A 25-gauge needle filled with HBSS (in mM: 5.0 KCl, 0.3 KH2PO4, 138 NaCl, 4.0 NaHCO3, 0.3 Na2HPO4·7H2O, 5.6 D-glucose, and 10.0 HEPES, with 2% antibiotics) was inserted into the aortic lumen opening while the whole heart remained in the ice-cold buffer solution. The opening of the needle was inserted deep into the heart close to the aortic valve and tied in place with the needle tip as close to the base of the heart as possible. The infusion pump started with a 20-ml syringe containing warm HBSS through an intravenous extension set at a rate of 0.1 ml/min for 15 min. HBSS was replaced with warm enzyme solution (1 mg/ml collagenase type I, 0.5 mg/ml soybean trypsin inhibitor, 3% BSA, and 2% antibiotic-antimycotic), which was flushed through the heart at a rate of 0.1 ml/min. Perfusion fluid was collected at 30-, 60-, and 90-min intervals. At 90 min, the heart was cut with scissors, and the apex was opened to flush out the cells that collected inside the ventricle. The fluid was centrifuged at 1,000 rpm for 10 min, the cell-rich pellets were mixed with the media described below, and the cells plated on 2% gelatin-coated six-well plates and incubated in 5% CO 2-95% O2 at 37°C. Advanced DMEM with 10% FBS, 10% mouse serum, and 2% antibiotics was then used to suspend isolated cells for the first stage culture. The medium was replaced three days later and then once or twice each week until the cells grew to confluence. Mouse CAMs were identified according to their morphology, immunohistological staining, Western blot analysis of marker proteins, and flow cytometric characteristics as described previously (33) .
RNA interference of TRP-ML1 in CAMs. Specific gene silencing was achieved by transfection of double-stranded small interfering (si)RNA targeting TRP-ML1 (Accession No.: BC118374) consisting of 5=-CAGCUUCCGGCUCCUG-3=. The scrambled small RNA (5=-AATTCTCCGAACGTGTCACGT-3=) was also confirmed as nonsilencing double-stranded RNA and used as a control in the present study. TRP-ML1 cDNA was prepared and used as we described previously (39) . Transfection of siRNA or cDNA was performed using the siLentFect Lipid Reagent or TransFectin Lipid Reagent (Bio-Rad) according to the manufacturer's instructions (40) . The efficiency of TRP-ML1 silencing was assessed by Western blot and real-time PCR analyses. The TRP-ML1 antibody was purchased from Santa Cruz Biotechnology (sc-48745).
Fluorescent confocal microscopic measurement of intracellular Ca 2ϩ and lysosome Ca 2ϩ release. As described in our previous study (38) , subconfluent CAMs in 35-mm cell culture dishes were loaded with the Ca 2ϩ -sensitive dye fluo-4 (5 M) in HBSS and then incubated at room temperature for 20 min. The fluo 4-loaded CAMs were then bathed with Ca 2ϩ -free HBSS buffer containing 1 mM EGTA. Ca 2ϩ imaging was performed using a laser scanning confocal microscope (Olympus Fluoview System, version 5.0, FV300), which consists of an Olympus BX61WI inverted microscope with an Olympus Lumplan F1ϫ60, 0.9 numerical aperture, and water-immersion objective. Pseudocolor Ca 2ϩ /fluo-4 fluorescence images were acquired at 488-nm excitation and Ͼ510-nm emission in the XYT recording mode with a speed of 2 frames/s. The Ca 2ϩ /fluo-4 fluorescence intensity was analyzed with Fluoview version 5.0 software. The ratio of Ca 2ϩ -dependent fluorescence intensity to that at the basal level was quantified as the intracellular Ca 2ϩ response. To detect lysosome Ca 2ϩ release, subconfluent CAMs in 35-mm cell culture dishes were incubated with dextran-conjugated tetramethylrhodamine (Rho; 1 mg/ml; Molecular Probes) for 4 h in advanced DMEM medium containing 10% FBS at 37°C, 5% CO 2, followed by a 20-h chase in dye-free medium for lysosomes loaded with Rho as previously described (5, 38) . After being washed with HBSS buffer three times, the Rho-loaded cells were then incubated with the Ca 2ϩ -sensitive dye fluo-4 at a concentration of 5 M. Ca 2ϩ release and lysosome trace recordings were performed in the presence of FasL (10 ng/ml) with or without the pretreatment with TRP-ML1 siRNA and cDNA as described above. Lysosome/Rho (Lyso/Rho) fluorescence images were acquired at 568-nm excitation and 590-nm emission. The colocalization coefficiency of Ca 2ϩ /fluo-4 and Lyso/ Rho was analyzed with Image-Pro Plus 6.0 software (41) .
Confocal microscopic colocalization of the lysosome marker Lamp1 with ryanodine receptor 3 in CAMs. For dual-staining detection of the colocalization of Lamp1 with ryanodine receptor 3 (RyR3), the CAMs were first incubated with FITC-labeled anti-Lamp1 antibody and then with rabbit anti-RyR3 polyclonal antibody (1:200; Santa Cruz, CA), followed by incubation with Texas red-conjugated anti-rabbit (1:500; Molecular Probes, Carlsbad, CA) secondary antibody. An excitation/emission wavelength of 570/625 nm was used for confocal microscopy of Texas red, and the colocalization was visualized by confocal microscopy.
Confocal microscopy of lysosome trafficking toward the SR. CAMs (2 ϫ 10 4 /ml) cultured in 35-mm dish were incubated with organelle lights SR-RFP (12 l/well; Invitrogen) in complete cell medium at 37°C for 16 h. Then, the medium from the dish was removed and prewarmed (37°C) medium containing LysoTracker Green (50 nM; Invitrogen) was added. The cells were incubated for 30 min under growth conditions, and the loading solution was replaced with the fresh medium (same volume). The confocal fluorescent microscopic recording was conducted with an Olympus Fluoview System. The fluorescent images for lysosomes (LysoTracker Green) and SR (SR-RFP) of the CAMs were continuously recorded at an excitation/ emission (nm) of 504/511 and 488/530 by using XYT recording mode with a speed of 2 frames/s for 15 min. The pixels between lysosomes and SR were measured by the Image Pro-Plus software. The relative value to basal pixels was calculated as the distance between lysosome and SR.
Flow cytometric detection of cell apoptosis. Apoptosis of CAMs was detected using an annexin V-propidium iodide (PI) double staining kit (Sigma, St. Louis, MO) according to the manufacturer's instructions. CAMs were trypsinized and collected by centrifugation at 500 g for 8 min at room temperature. The cells were washed in cold (2-8°C) PBS and then subjected to another centrifugation. Then, the cells were resuspended in the annexin V-PI reagent for 10 min at a concentration of 1 ϫ 10 6 cells/100 l. After resuspension and washing with the reaction, the cells were detected using a flow cytometer (GUAVA, Hayward, CA) within 1 h. Annexin V-positive-PI-negative cells were considered as apoptotic. The percentage of cells to total cells was calculated as the rate of apoptotic cells (see Fig. 6A , bottom right).
Assay of calpain and calcineurin activity. Fluorogenic substrate assays were performed with Suc-Leu-Leu-Val-Tyr-AMC (Suc-LLVY), a membrane-permeable calpain-specific fluorogenic substrate as previously described (24) . Proteolytic hydrolysis of the peptidyl-7-amilorideno bond liberates the highly fluorescent 7-amilorideno-4-methylcoumarin (AMC) moiety. Cellular fluorescence was quantified by fluorometry with 360-nm excitation and 460-nm emission filters. Standard curves were generated with free AMC for each experiment. For measurements of calpain activity, CAMs were plated at 10 5 cells in 200 l medium per well in 96-well plates and incubated for 24 h at 37°C. The medium was removed from the adherent cell layer, and cells were then treated with FasL. After a 15-min incubation at 37°C, 200 l of assay buffer (115 mM NaCl, 1 mM KH 2PO4, 5 mM KCl, 2 mM CaCl2, 1.2 mM MgSO4, and 25 mM sodium HEPES buffer at pH 7.4) were added to all wells. To determine the maximal calpain activity under our experimental conditions, the Ca 2ϩ ionophore A23187 (5 mM) was added to representative wells. As an additional control to ensure that fluorescence activity was calpain specific, aLLN (50 mM) was added to representative wells for each condition. Other controls included aLLN alone, A23187 alone, and FasL alone in the absence of cells. Suc-LLVY substrate (62.5 mM) was added to each well at the start of the assay. The plates were incubated at 37°C in the fluorometer, and fluorescence was measured at 5-min intervals starting immediately after the addition of substrate. Calpain activity was calculated as mean fluorescence Ϯ SE. For conditions with the Ca 2ϩ ionophore A23187, the inherent fluorescence of this compound (determined from wells containing A23187 in the absence of cells) was subtracted from the total measured fluorescence to accurately represent maximal calpain activity. For comparison of calpain activity at 120 min, the net calpain activity under FasL treatment was calculated by subtracting the residual activity in the presence of calpain inhibitor.
In addition, calcineurin activity was determined according to manufacturer's kit (BML-AK816; Enzo). The detection of free-phosphate in the supernatant by colorimetric assay represented the activity of calcineurin in mouse CAMs.
Statistics. Data are presented as means Ϯ SE. Significant differences between and within multiple groups were examined using ANOVA for repeated measures, followed by Duncan's multiple-range test. A Students' t-test was used to detect significant differences between two groups. P Ͻ 0.05 was considered statistically significant.
RESULTS

Efficiency of TRP-ML1 siRNA or cDNA on TRP-ML1 channel expression.
RT-PCR and Western blot analysis were used to demonstrate the efficiency of TRP-ML1 gene silencing by siRNA transfection or overexpression of TRP-ML1 gene by introduction of a full-length TRP-ML1 gene in CAMs. As shown in Fig. 1A , the mRNA level of TRP-ML1 was reduced by 72.4% after transfection of TRP-ML1 siRNA but increased by 1.43 fold after TRP-ML1 gene transfection in CAMs. Furthermore, Western blot analysis as presented in Fig. 1 , B and C, showed that the protein expression of TRP-ML1 decreased by 63.5% and increased by 97.6% by TRP-ML1 siRNA or a full-length gene transfection respectively.
RNA interference of TRP-ML1 blocked Fas activation-induced lysosomal Ca
2ϩ bursts. To determine the role of lysosomal TRP-ML1 channels in the two-phase Ca 2ϩ release, fluorescent imaging analysis was conducted to test the effects of TRP-ML1 inhibition on the Ca 2ϩ release in intact CAMs in response to FasL. In Fig. 2A sion wavelength of ϳ504/511 nm. The SR was labeled with organelle Lights SR-RFP, which is a TagRFP fused to the SR signal sequence of calreticulin and KDEL (SR retention signal). As shown in Fig. 5A , typical fluorescent images of CAMs were taken at 0, 1, 3, 5, and 7 min in control or FasL-treated cells. Under control condition, lysosomes were located near SR strands. FasL induced an obvious trafficking of lysosomes toward the SR (as showed by arrows), as confirmed by the decreased distance between the lysosomes and SR in a timedependent manner (Fig. 5B) . The summarized data in Fig. 5B showed that the dynamic movement of lysosomes to the SR was decreased after the TRP-ML1 siRNA transfection.
TRP-ML1 Ca 2ϩ release contributed to FasL-induced apoptosis. First, we used annexin V-PI double-stained CAMs to measure apoptosis and found that FasL doubled apoptotic CAMs compared with vehicle treatment (Fig. 6, A and B) . When CAMs were transfected with TRP-ML1 siRNA, FasL-induced apoptosis was markedly suppressed by 45.7%. However, FasLinduced apoptosis was markedly increased by TRP-ML1 overexpression in CAMs (58.8%). Since calpain and calcineurin are two important effectors of intracellular Ca 2ϩ , which initiate apoptosis (28, 34) , we examined whether they are involved in FasL-induced apoptosis in CAMs. With the use of cyclosporin A and PD150606, the selective inhibitor of calcineurin and calpain, respectively, we demonstrated that FasL-induced apoptosis was attenuated by 62.8% by cyclosporin A and by 40.6% by PD150606, suggesting that both calcineurin and calpain are indeed involved in FasL-induced apoptosis in CAMs (Fig. 6C) .
Calpain and calcineurin activity in CAMs. We further determined whether the activities of calpain and calcineurin can be altered by increase or decrease in TRP-ML1 gene expres- sion. As shown in Fig. 7A , FasL-treated CAMs had much higher calpain activity than control CAMs. This FasL-induced calpain activation was significantly attenuated by TRP-ML1 gene silencing. In contrast, calpain activity was markedly increased by TRP-ML1 gene overexpression in CAMs. Figure  7B shows that FasL tripled calcineurin activity in scramble RNA transfected CAMs and that this FasL-induced enhancement of calcineurin activity was markedly attenuated by TRP- ML1 gene silencing but significantly enhanced by TRP-ML1 gene overexpression. In the presence of cyclosporin A or PD150606, the FasL-induced calcineurin activation in CAMs was markedly suppressed (Fig. 7C) .
DISCUSSION
The present study provides the first direct evidence that TRP-ML1 channel activity is implicated in FasL-induced lysosomal Ca 2ϩ bursts and consequent global Ca 2ϩ increase due to its mobilization from the SR. This TRP-ML-1-mediated two-phase Ca 2ϩ release is associated with lysosome trafficking toward and interaction with the SR. We also demonstrated that FasL induced apoptosis in CAMs through activation of lysosomal TRP-ML1 channels and associated Ca 2ϩ release responses.
Although FasL was previously reported to stimulate lysosomal Ca 2ϩ bursts followed by a global increase in intracellular Ca 2ϩ concentrations (38) , it remains unknown how these lysosomal Ca 2ϩ bursts are produced upon FasL stimulation and what mechanism mediates the coupling of lysosomal Ca 2ϩ bursts to the SR Ca 2ϩ release. The present study first determined whether lysosomal TRP-ML1 channel activity is involved in FasL-induced two-phase intracellular Ca 2ϩ release and then tested whether this action of lysosomal TRP-ML1 channels is attributed to lysosome trafficking toward the SR, where a large Ca 2ϩ release is activated to cause global Ca 2ϩ increases in CAMs. We demonstrated that FasL-induced lysosomal Ca 2ϩ release and consequent Ca 2ϩ release from the SR were blocked or enhanced, respectively, by silencing or overexpression of TRP-ML1 gene in mouse CAMs. This supports the view that lysosomal TRP-ML1 channel is critically implicated in the Ca 2ϩ response to FasL stimulation. Similar to the inhibitory effect of TRP-ML1 siRNA, pharmacological intervention to TRP-ML1 channel activity with amiloride or lanthanum also significantly attenuated FasL-induced two-phase Ca 2ϩ release in CAMs (data were not shown). However, both pharmacological interventions and RNA interference of the TRP-ML1 gene had no effect on Ca 2ϩ release induced by oxotremorine, an agonist that uses RyR-mediated Ca 2ϩ signaling pathway or by U46619, a typical agonist using IP 3 receptor-mediated Ca 2ϩ signaling mechanism. These results suggest that activation of TRP-ML1 channels is specific to mediate FasL-induced signal transduction through a two-phase Ca 2ϩ release. To our knowledge, these results are the first time to link FasL action to lysosomal TRP-ML1 channel-mediated signaling.
Since lysosomal Ca 2ϩ concentrations are maintained in part by the proton gradient across lysosome membrane (9) and V-H ϩ -ATPase as a lysosome resident proton pump to maintain an acidic milieu in the lysosomal lumen may drive Ca 2ϩ uptake into the lysosomes by Ca 2ϩ /H ϩ exchange, inhibition of V-H ϩ -ATPase may also cause the depletion of lysosomal Ca 2ϩ storage and thereby lead to no Ca 2ϩ release response via TRP-ML1. We also tested this possibility in CAMs. Similar to TRP-ML1 gene silencing, FasL-induced Ca 2ϩ release from lysosomes and subsequently from the SR was substantially blocked by pretreatment of CAMs with bafilomycin, a specific inhibitor of lysosomal V-H ϩ -ATPase (Supplemental Fig. S1 ). This further supports the view that FasL-induced Ca 2ϩ release response is associated with lysosomal Ca 2ϩ store. However, these experiments using bafilomycin may not exclude the role of other lysosomal Ca 2ϩ release channels such as two-pore channels (TPCs). It has been reported that TPCs are present in the endo/lysosomal system and they may be a Ca 2ϩ release channel in lysosomes (22, 29) . However, the present study showed that the siRNA of TPC2, a major TPC reported to mediate lysosomal Ca 2ϩ release, had no inhibitory effect on FasL-induced Ca 2ϩ release from lysosomes of CAMs (Supplemental Fig. S2 ). In addition, a most recent study reported that TPC in endo/lysosomes primarily functions as a sodium channel (31) . Taken together, all these results indicate that lysosomal TRP-ML1 channels mediate FasL-induced two-phase intracellular Ca 2ϩ release in mouse CAMs. We next addressed how Ca 2ϩ bursts produced by lysosomal TRP-ML1 channels trigger the Ca 2ϩ release from the SR. It has been reported that CICR triggers release of Ca 2ϩ from the SR without the simultaneous action of other activating processes in a variety of mammalian cells (7, 14) . Traditionally, CICR produces global intracellular Ca 2ϩ increase in milliseconds or seconds and is then inactivated. However, recent studies in our laboratory and by others showed that a slow CICR process is involved in the occurrence of the second phase of Ca 2ϩ increase in different cells in response to different agonists such as ET-1 and FasL (4, 12, (37) (38) . This slow CICR is featured by a delay of minutes after the first phase of Ca 2ϩ bursts from lysosomes, which is temporally very different from the classic CICR. Given the great mobility of lysosomes within cells, it is possible that Ca 2ϩ bursts from individual lysosomes may not be enough to trigger the SR Ca 2ϩ release, but such Ca 2ϩ bursts are able to stimulate lysosome trafficking toward the SR. When increasing numbers of lysosomes aggregate around the SR, local Ca 2ϩ concentrations increase to reach a threshold for activation of RyR or IP 3 receptor, thereby resulting in a large SR Ca 2ϩ release. In the present study, we first observed an increased colocalization of the lysosomal marker Lamp1 with RyR3 when CAMs were stimulated by FasL. Then, a dynamic movement of lysosomes toward the SR was demonstrated upon FasL stimulation. Importantly, inhibition of TRP-ML1 channel activity or silencing its gene blocked the colocalization of Lamp-1 and RyR3 and attenuated the interactions of lysosomes with the SR. These results confirm our hypothesis that lysosomes are trafficking toward the SR upon FasL stimulation and that TRP-ML1 channel activity is critical in such lysosome trafficking, which triggers CICR and leads to a large Ca 2ϩ release from the SR. It is obvious that lysosome movement and subsequent accumulation of Ca 2ϩ around aggregated lysosomes in the proximity of the SR result in a delay of the second phase of Ca 2ϩ release from the SR. This time delay of the Ca 2ϩ release from the SR was also observed in a number of other cell types such as starfish eggs, sea urchin eggs, and pancreatic acinar cells (6, 10, 23) , which is now attributed to the lysosome trafficking and aggregation around the SR.
The present study also addressed the importance of TRP-ML1 channel activity in the regulation of apoptosis in CAMs. It has been reported that increased cytosolic Ca 2ϩ contributes to the activation and progression of apoptosis in response to different death factors such as FasL, TNF-␣, and TNF-related apoptosis-inducing ligands (TRAILs; Refs. 1, 3, 17, 25) . However, it remains unknown whether the Ca 2ϩ release from lysosomes via TRP-ML1 channels plays a role in apoptosis of CAMs upon activation of death receptors such as Fas. In the present study, using flow cytometry we demonstrated that FasL increased annexin V-positive CAMs, indicating enhanced apoptosis. However, inhibition of TRP-ML1 activity or silencing of the TRP-ML1 gene significantly suppressed, but TRP-ML1 gene overexpression significantly enhanced, FasL-induced apoptosis of CAMs. This role of TRP-ML1 channels in apoptosis of CAMs was also observed by using TRP-ML1 channel blockers, amiloride, and lanthanum. These results suggest that the functional TRP-ML1 channels are the prerequisite for FasL to induce apoptosis in CAMs. Although previous studies have shown that FasL-mediated apoptosis requires Ca 2ϩ release from the ER through IP 3 in Jurkat T-lymphoma cells (32) , the mechanism mediating FasL-induced activation of IP 3 signaling remains unclear. It is possible that the action of FasL on IP 3 signaling is also due to lysosomal Ca 2ϩ bursts associated with the TRP-ML1 activity. In this way, activation of TRP-ML1 channel produces lysosomal Ca 2ϩ bursts and consequently leads to CICR associated with lysosome trafficking, resulting in IP 3 receptor activation and the large Ca 2ϩ release from the SR.
To further explore the mechanisms by which TRP-ML1 channel-mediated lysosome Ca 2ϩ bursts induce apoptosis during activation of Fas, we analyzed the activities of calpain and calcineurin, two Ca 2ϩ sensitive apoptosis-activating enzymes. It is well known that calpain is a Ca 2ϩ -activated neutral cysteine protease that catalyzes limited proteolysis of substrate proteins (34 -36) , which directly activates caspases to promote apoptosis with ER stress independent of mitochondrial cytochrome c release (20) . Calcineurin is a widely distributed protein phosphatase, and it belongs to the protein phosphatase 2B family of Ca 2ϩ /calmodulin-dependent serine/threonine protein phosphatases (13) . The activation of calcineurin may initiate mitochondrial dysfunction and further stimulate the mitochondria-dependent cell death pathway (16, 21, 28) . In the present study, we found that FasL-increased activity of calpain and calcineurin was almost completely inhibited by TRP-ML1 blockers or its siRNA but augmented by overexpression of TRP-ML1 gene. With the use of their selective inhibitors, FasL-induced enhancement of calpain or calcineurin activity was blocked to a similar extent to that induced by TRP-ML1 blockers or siRNA. These results further confirm a novel pathway mediating apoptosis of CAMs, which is associated with activation of lysosomal TRP-ML1 channels and consequent Ca 2ϩ -sensitive protease activity. In summary, we demonstrated that TRP-ML1 channels are importantly implicated in FasL-induced Ca 2ϩ release from lysosomes in CAMs. This lysosomal Ca 2ϩ burst promotes lysosome trafficking toward the SR, where aggregated lysosomes with more Ca 2ϩ bursts interact with the SR, producing a large Ca 2ϩ release from the SR via CICR in CAMs. Another important finding of the present study is that TRP-ML1-mediated Ca 2ϩ signaling is critical to the apoptosis of CAMs, and its role is attributed to Ca 2ϩ -dependent activities of apoptosis-activating enzymes such as calpain and calcineurin. It is concluded that the activation of lysosomal TRP-ML1 channels critically mediates the two-phase Ca 2ϩ release in CAMs, which may represent a novel mechanism leading to apoptosis of these cells in response to FasL stimulation.
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